Vivozon Pharmaceutical stock price

비보존 제약KRX:082800 · KOSDAQ · Healthcare · sector #23
₩3,010-0.66%
2026-10-08 close
Loading chart…

Vivozon Pharmaceutical's chart data is dated 2026-10-08. Recorded technical signals: MACD bullish cross. There are 0 published signal records.

Vivozon Pharmaceutical last closed at ₩3,010 (-0.66%) on 2026-10-08. Signals today: MACD bullish cross. Listed on KOSDAQ. Trailing 12 months PER is -5.5×. Its overall grade ranks 160 of 308 stocks in Healthcare.

About this company

Vivozon Pharmaceutical last closed at ₩3,010 (-0.66%) on 2026-10-08. Signals today: MACD bullish cross. Listed on KOSDAQ.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall B- · 160/308

Valuation grade B-

Details →

Recent filings

DART · received recent list, not a complete filing history. Factual information, not investment advice.

Details →

Related stocks

  • 대원제약Competitor

    진통제·의약품 중심의 국내 제약 경쟁사

  • 종근당Competitor

    처방의약품과 진통제·호흡기 등에서 경쟁

  • 한미약품Competitor

    국내 전문의약품 시장에서 주요 경쟁사

Details →
About Vivozon Pharmaceutical
What technical signals does Vivozon Pharmaceutical (082800) have?
Vivozon Pharmaceutical current technical signals: MACD bullish cross.
Is Vivozon Pharmaceutical a cup-and-handle pattern?
No. Vivozon Pharmaceutical has no valid Cup signal right now.
What published figures are available for Vivozon Pharmaceutical?
Market cap: KRW 158.7B. Trailing 12 months PER: -5.5×. Latest quarter PBR: 1.91×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Major stocks in the same sector

2026-10-09 dataset

Disclosed suppliers

2026-03-23 dataset

Turn what you saw on this name into a strategy

Ask Q about Vivozon Pharmaceutical, or open the plan table on the main site.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Vivozon Pharmaceutical notifications

Quantus Signal · live data · not investment advice · Privacy Policy